Late-stage pipeline is dominated by follicle stimulating hormones, split between “biobetters” and biosimilars. Next-generation oxytocin antagonists are leading candidates for the next novel entities in infertility.

Ovuline Inc. is using powerful algorithms based upon the input of more than two million fertility-related data points to help women conceive faster and have a healthy pregnancy. Its web- and mobile app-based product, Smart Fertility, takes into account personal information entered by its users to help predict when ovulation will occur and offer advice about what to do every day to maximize fertility.

Fertility Focus has two products that it says address 85% of the causes of female infertility, and assist in earlier diagnosis and treatment: the OvuSense home-use ovulation detection and fertile period predictor and the FertiloScope, a trans-vaginal laparoscopic instrument that is designed to diagnose and treat the main physical causes of female infertility in one minimally invasive outpatient procedure.